TUMOR-LN-OC

Tumor-LN-oC proposes the development and validation of a TRL 5 tumor-lymph node-on-chip platform composed of 3D tissue models and microfluidic chips which will connect surgically removed human primary tumors and lymph node tissue (LN) from the same lung cancer patient. This will serve as a "biological twin" of the patient and will allow Tumor-LN-oC consortium to study the interaction of primary tumors with LNs for individual patients.